Form 4 Filing: Lyons-Williams Lori Acquires (Grant) shares of $CTNM

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

Contineum Therapeutics, Inc.

Ticker: $CTNM

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-06-26

Shares: 19,000

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Lyons-Williams Lori, holds the title of Director at Contineum Therapeutics, Inc..

On 2026-06-26, the insider transacted 19,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Lyons-Williams Lori (Director) was granted $0 of $CTNM

Post-Transaction Position: 19,000 shares

SEC Accession No: 0001628280-26-045843 (CIK: 1693564)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$CTNM Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$CTNM News Coverage